Feb 8, 2024 07:03AM
Feb 8, 2024 07:00AM
May 19, 2023 02:03PM
Apr 24, 2023 07:03AM
Apr 24, 2023 07:00AM
Jan 18, 2023 07:01AM
Jun 22, 2022 07:03AM Krystal Biotech (KRYS) Submits BLA to U.S. FDA Seeking Approval of B-VEC for the Treatment of Patients with Dystrophic Epidermolysis Bullosa
Jul 1, 2021 04:15PM
Jan 24, 2020 08:00AM
Jan 21, 2020 08:00AM
Nov 26, 2019 08:00AM
Oct 10, 2019 08:02AM
Oct 10, 2019 08:00AM
Sep 30, 2019 08:00AM Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference and Chardan's 3rd Annual Genetic Medicines Conference
Sep 27, 2019 08:04AM
Sep 27, 2019 08:00AM
Sep 4, 2019 08:11AM
Sep 4, 2019 08:00AM
Aug 27, 2019 04:05PM
Jul 1, 2019 09:05AM
Jun 14, 2019 08:02AM Krystal Biotech (KRYS) Submits IND Application for KB105
Jun 14, 2019 08:00AM
May 15, 2019 08:00AM
Apr 29, 2019 08:00AM
Mar 29, 2019 08:07AM
Mar 29, 2019 08:00AM
Mar 12, 2019 08:00AM
Mar 6, 2019 08:00AM Krystal Biotech Continues Vertical Integration with Official Inauguration of Ancoris Gene Therapy Manufacturing Facility at its Pittsburgh Headquarters
Mar 4, 2019 08:06AM
Mar 4, 2019 08:00AM
Mar 1, 2019 08:00AM
Feb 22, 2019 08:00AM
Jan 15, 2019 08:00AM
Dec 19, 2018 08:00AM
Nov 20, 2018 08:00AM Krystal Biotech to Present at Evercore ISI HealthCONx
Oct 4, 2018 04:05PM
Oct 1, 2018 08:00AM
Sep 25, 2018 08:00AM
Aug 29, 2018 04:05PM
Aug 6, 2018 08:00AM
Jul 16, 2018 08:00AM
May 24, 2018 08:07AM Krystal Biotech (KRYS) Granted FDA Fast Track Designation for KB103 for Treatment of Dystrophic Epidermolysis Bullosa
May 24, 2018 08:00AM
May 10, 2018 09:18AM
May 10, 2018 09:18AM
May 9, 2018 08:00AM
May 7, 2018 08:00AM
Apr 26, 2018 08:10AM
Apr 26, 2018 08:00AM Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa
Apr 19, 2018 08:00AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All